GlassScriptPhysician profile
Ahsan M Bhatti
NPI 1518934736
$3,608.91
in general payments reported to CMS, 2019-2025
34 companies · $579 in 2025
The $579 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $360 · 2020: $246 · 2021: $870 · 2022: $380 · 2023: $716 · 2024: $457 · 2025: $579.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,752.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,752.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Apollo Endosurgery US INC | $733.04 | 2019-2023 | Overstitch Endoscopic Suturing System |
| Boston Scientific Corporation | $676.00 | 2019-2025 | Apollo Esg System, Axonics, Overstitch Endoscopic Suturing System |
| Celgene Corporation | $481.67 | 2021-2024 | Zeposia |
| Enterra Medical, INC. | $239.29 | 2022-2024 | |
| Axonics, INC. | $206.63 | 2020-2022 | |
| Medtronic, INC. | $164.26 | 2021-2025 | Interstim |
| Janssen Biotech, INC. | $142.70 | 2020-2022 | |
| Abbvie INC. | $140.41 | 2021-2024 | Rinvoq, Linzess |
| Intuitive Surgical, INC. | $85.23 | 2023 | Da Vinci Surgical System |
| Capsovision, INC. | $82.50 | 2025 | Capsocam Plus |
| Daiichi Sankyo INC. | $73.22 | 2021-2022 | |
| Novo Nordisk INC | $72.99 | 2019-2022 | |
| Karl Storz Endoscopy-America | $50.99 | 2021 | |
| Organon LLC | $40.67 | 2023 | Renflexis |
| Digestive Care, INC. | $39.04 | 2019 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Qol Medical, LLC | $34.08 | 2019 | |
| Ferring Pharmaceuticals INC. | $32.35 | 2022-2023 | Rebyota |
| Romark Laboratories, Lc | $32.35 | 2020 | |
| Medtronic USA, INC. | $28.35 | 2019-2020 | |
| Pfizer INC. | $26.67 | 2020-2021 | |
| Mauna Kea Technologies, INC. | $24.94 | 2021 | |
| Lilly USA, LLC | $24.89 | 2025 | Omvoh |
| Ucb, INC. | $19.45 | 2022 | |
| Alfasigma USA, INC. | $19.16 | 2020 | |
| Genzyme Corporation | $15.32 | 2022 | |
| Ipsen Biopharmaceuticals, INC | $15.24 | 2023 | Bylvay |
| Endogastric Solutions, INC | $14.83 | 2021 | |
| Nestle Healthcare Nutrition INC. | $14.29 | 2022 | |
| Merck Sharp & Dohme LLC | $13.79 | 2023 | |
| Aimmune Therapeutics, INC. | $13.76 | 2024 | |
| Ardelyx, INC. | $13.51 | 2022 | |
| Phathom Pharmaceuticals, INC. | $13.23 | 2023 | Voquezna |
| Ironwood Pharmaceuticals, INC | $12.60 | 2020 | |
| Itamar Medical INC | $11.46 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ahsan Bhatti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.